CMS NewsroomMedicare & Medicaid

CMS Extends Deadlines for GENEROUS Model Applications for Drug Manufacturers and States

Plain English Summary

The Centers for Medicare & Medicaid Services (CMS) has extended the application deadlines for drug manufacturers and states interested in the GENEROUS Model, which aims to improve access to medications for Medicaid programs. Drug manufacturers now have until June 11, 2026, to apply, and states have until September 10, 2026, to submit their applications. This extension allows more time for smaller manufacturers and state programs to prepare their applications and agreements. Agents should inform eligible drug manufacturers and state Medicaid programs about these new deadlines and encourage them to participate.

Read the original source

medicaid drug-prices health-plans compliance

+View original text

Administration Drug Prices Share CMS Extends Deadlines for GENEROUS Model Applications for Drug Manufacturers and States Following overwhelming interest from prescription drug manufacturers, the Centers for Medicare & Medicaid Services (CMS) is extending the application deadline for drug manufacturers to apply to the GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) Model. The deadline extension to June 11, 2026, from April 30, 2026, provides interested drug manufacturers, particularly those that are small to mid-sized, with more time to engage with the CMS Innovation Center, review participation information and prepare their application to join the model. Additionally, CMS is extending the deadline for drug manufacturers to enter into participation agreements from June 30, 2026, to July 17, 2026. Companies that manufacture at least one drug and that participate in the Medicaid Drug Rebate Program are eligible to apply to participate in the GENEROUS Model, which is intended to offer improved and streamlined access for state Medicaid programs to participating manufacturers’ products. Interested drug manufacturers that wish to schedule a meeting with CMS about their potential participation in the model should contact generousmodel@cms.hhs.gov . CMS is also extending the deadline for states to apply to the GENEROUS model from July 31, 2026, to September 10, 2026, and to finalize participation agreements from August 31, 2026, to September 30, 2026. State Medicaid programs that choose to participate in the GENEROUS Model, announced in November 2025 , will be able to purchase drugs included in the model at prices aligned with those paid in select other countries, allowing state Medicaid programs to benefit from fairer, more competitive pricing. Additional information on the GENEROUS Model is available on the model webpage , including the Request for Applications for drug manufacturers . ### Get CMS news at cms.gov/newsroom , sign up for CMS news via email and follow CMS on X @CMSgov Previous Newsroom Article